"Navigating the Modern News Zoo so you don't have to."
Friday, June 6, 2025
Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy
For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-positive breast cancer, elinzanetant, a neurokinin-targeted therapy, reduces the frequency of vasomotor symptoms, according to a study published online June 2 in the New England Journal of Medicine to coincide with the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.
👉 Full Story
Chaos erupts at Family Dollar when Black cashier won't refund White woman's shirt #shorts
- Why Do You Crave Salt? Causes and Tips To Reduce Cravings - Chelsea Rae Bourgeois, RDN, LD
- Thrown into the ocean, pregnant cat lives up to her new name
- Adopting a healthy diet may have cardiometabolic benefits regardless of weight loss
- Israel Says Hamas Spreading ‘False Information’ About Gaza Shootings - Diana Zapata
- ECU Health Bertie Hospital named among top critical access hospitals - corey.keenan
- Star Trek: Voyager's Best Special Effect Was Almost A Disappointment - Chris Snellgrove
Do Not Buy iPhones Right Now!
- A dangerous E. coli strain has emerged; a small mutation may explain its rise - Beth Mole
- An In-depth Look at Boeing 737 Max's Recent Issues: Safety Concerns and Industry Implications - Bertha Stephens
- Jean-Pierre Reportedly Had Hopes of Hosting Popular Lib Hack TV Show, but Opted for Tell-All Book
- Why Harvard Hits Rock Bottom: A Crisis of Leadership, Integrity, and Purpose - Diana Zapata
- Can You Detox From Microplastics? Here's What the Science Says - Kaitlin Sullivan
- Healthy man goes camping—lands in ICU for 40 days with respiratory failure - Beth Mole
